Analystreport

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com